Development and validation of a patient symptom questionnaire to facilitate early diagnosis of thyroid-associated orbitopathy in Graves' disease

Orbit

Volumn 27, Issue 6, 2008, Pages 419-425

  Mohaseb, Kam ^a   Linder, Mark ^a   Rootman, Jack ^a,b   Wilkins, G E ^b   Schechter, Martin T ^b   Dolman, Peter J ^b   Singer, Joel ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Graves' hyperthyroidism; Questionnaire; Screening; Thyroid orbitopathy; Validation

Indexed keywords

ARTICLE; CANCER SCREENING; CLINICAL EVALUATION; CLINICAL EXAMINATION; CLINICAL PRACTICE; COHORT ANALYSIS; CRITERION RELATED VALIDITY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HUMAN; OPHTHALMOLOGY; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SYMPTOM; SYMPTOMATOLOGY; VALIDATION PROCESS; VALIDATION STUDY;

EARLY DIAGNOSIS; FALSE NEGATIVE REACTIONS; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; IODINE RADIOISOTOPES; ORBITAL DISEASES; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; THYROID NEOPLASMS; THYROTOXICOSIS; THYROTROPIN; WHOLE BODY IMAGING;

EID: 57649129036     PISSN: 01676830     EISSN: 17445108     Source Type: Journal    
DOI: 10.1080/01676830802414566     Document Type: Article

References (15)

1. Bahn RS. Clinical review 157: Pathophysiology of Graves' ophthalmopathy: The cycle of disease. J Clin Endocrinol Metab. 2003;88;1939-1946.
2. Bahn RS, Heufelder AE. Pathogenesis of Grave's ophthalmopathy. N Engl J Med. 1993;329:1468-1475.
3. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, et al. The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol. 1995;120:511-517.
4. Berglund J, Christensen SB, Hallengren B. Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goiter, and solitary toxic adenoma in Malmo 1970-4. J Intern Med. 1990;227:137-141.
5. Boulos PR, Hardy I. Thyroid-associated orbitopathy: A clinicopathologic and therapeutic review. Curr Opin Ophthalmol. 2004;15:389-400.
6. Char D. Thyroid Eye Disease. 4th ed. Boston, MA: Butterworth-Heinemann; 2001.
7. Dickenson AJ, Perros P. Clinical endocrinology: Controversies in the clinical evaluation of active thyroid-associated orbitopathy: Use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol. 2001;55:283-303.
8. Dolman PJ, Rootman J. VISA classification for thyroid-related orbitopathy. In: Rootman J, editor, Orbital Disease: Present Status and Future Challenges. Boca Raton, FL: Taylor & Francis, 2005:253-259.
9. Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hording M, Perrild H, Waldemar G. Impaired health-related quality of life in Graves' disease. A prospective study. Eur J Endocrinol. 2004;151:549-555.
10. Jacobson DH, Gorman CA. Endocrine ophthalmopathy: Current ideas concerning aetiology, pathogenesis, and treatment. Endocr Rev. 1984;5:200-220.
11. Kendler D, Lippa J, Rootman J. The initial clinical characteristics of Graves' orbitopathy vary with age and sex. Arch Ophthalmol 1993;111:197-201.
12. Perros P, Crombie AL, Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol. 1995;42:45-50.
13. Perros P, Crombie AL, Mathews JN, Kendall-Taylor P. Age and gender in-fluence the severity of thyroid-associated ophthalmopathy: A study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol. 1993;38:367-372.
14. Rootman J. Diseases of the Orbit: A Multidisciplinary Approach. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003.
15. Steinberg MW, Diener-West M, Bass EB, Damiano AM. The VF-14. An index of functional impairment in cataract patients. Arch Ophthalmol. 1994;112:630-638.